DNLI - Denali Therapeutics Inc.

📈 Is growth accelerating? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	N/M	N/M	N/M	N/M	-64.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-905%)	460.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5656%)	-16.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-308%)	-17.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-323%)	-32.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-508%)	128.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1510%)	431.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5299%)	-96.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1301%)	-43.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-647%)	292.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3554%)	119.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1398%)	6681.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+83414%)	-31.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-487%)	39.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+391%)	-14.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-279%)	-96.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1304%)	1038.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+12880%)	154.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1833%)	556.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6850%)	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	11.5% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-7.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-17.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-22.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-14.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	21.8% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	12.5% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	15.0% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-16.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	14.3% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-50.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-21.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-21.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	4.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	8.6% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-27.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	10.7% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	3.4% Caution ↑ Caution Improving Year-over-year change in net income	-12.0% Weak ↑ Weak Improving Year-over-year change in net income	-18.4% Weak ↓ Weak Declining Year-over-year change in net income	-25.3% Weak ↓ Weak Declining Year-over-year change in net income	-30.6% Weak ↓ Weak Declining Year-over-year change in net income	4.0% Caution ↑ Caution Improving Year-over-year change in net income	-7.9% Weak ↓ Weak Declining Year-over-year change in net income	N/M	7.3% Fair ↑ Fair Improving Year-over-year change in net income	-21.1% Weak ↑ Weak Improving Year-over-year change in net income	3.8% Caution ↑ Caution Improving Year-over-year change in net income	N/M	-68.3% Weak ↓ Weak Declining Year-over-year change in net income	-31.1% Weak ↓ Weak Declining Year-over-year change in net income	-22.1% Weak ↓ Weak Declining Year-over-year change in net income	3.1% Caution ↑ Caution Improving Year-over-year change in net income	6.9% Fair ↑ Fair Improving Year-over-year change in net income	N/M	-45.3% Weak ↓ Weak Declining Year-over-year change in net income	-3.3% Weak ↑ Weak Improving Year-over-year change in net income	-23.4% Weak ↓ Weak Declining Year-over-year change in net income	N/M	-25.9% Weak ↓ Weak Declining Year-over-year change in net income	-0.7% Weak ↑ Weak Improving Year-over-year change in net income	-45.6% Weak ↓ Weak Declining Year-over-year change in net income	N/M	-30.8% Weak ↑ Weak Improving Year-over-year change in net income	-6.6% Weak ↑ Weak Improving Year-over-year change in net income	-64.7% Weak ↑ Weak Improving Year-over-year change in net income	N/M	-61.9% Weak ↑ Weak Improving Year-over-year change in net income	-147.2% Weak Weak Year-over-year change in net income	-11.1% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	10.2% Fair Fair Year-over-year change in free cash flow	—	—	—	-2.9% Weak Weak Year-over-year change in free cash flow	—	—	—	-71.8% Weak Weak Year-over-year change in free cash flow	—	—	—	27.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-41.5% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	—	—	—	—	-48.7% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	269.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	113.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	30.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	-36.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	132.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	115.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-53.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	64.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	140.6% Excellent Excellent Compound annual revenue growth over 3 years	131.2% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	—	—	—	—	—	—	—	—	—	—	1.2% Caution ↓ Caution Declining Compound annual revenue growth over 5 years	182.0% Excellent Excellent Compound annual revenue growth over 5 years	122.7% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	58.0% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+286%)	-343.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2392%)	—	—	-117.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-880%)	-157.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1152%)	—	—	-269.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1897%)	—	77.0% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+414%)	—	—	—	—	-368.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2558%)	—	—	59.5% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+297%)	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	62.3% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+420%)	-312.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2703%)	—	—	-112.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1034%)	-154.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1390%)	—	—	-264.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2305%)	—	77.3% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+544%)	—	—	—	—	-340.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2934%)	—	—	61.7% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+414%)	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	-175.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	-180.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	161.8% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	-6.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	-244.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	73.0% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.04x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.14x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.56x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.17x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.76x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	2.09x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.01x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.18x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗
Return on Invested Capital (%)	-11.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.7% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-11.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.4% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-6.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	11.3% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.7% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-6.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	16.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-8.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	10.8% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-4.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—
Return on Capital (%) (%)	-10.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-13.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-9.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	13.1% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	-8.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-8.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	—	-5.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-4.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-8.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-6.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-7.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-10.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-4.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—
Return on Common Equity (%) (%)	-13.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-192%)	-12.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-185%)	-13.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-191%)	-12.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-181%)	-11.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-179%)	-9.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-162%)	-8.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-154%)	-7.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-148%)	-7.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-147%)	-11.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-177%)	-8.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-159%)	15.5% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	-11.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	-9.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-163%)	-12.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-185%)	-6.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-144%)	-7.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-147%)	-7.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-152%)	-8.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-156%)	-5.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-138%)	-6.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-142%)	21.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+42%)	-6.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-144%)	-11.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-178%)	-10.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-169%)	-13.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-191%)	-10.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-12.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-182%)	-7.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-150%)	14.2% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-5%)	-7.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-151%)	-11.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-174%)	-4.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-129%)	-4.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-133%)	—	—	—	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗
Net Debt (USD)	$-387.63M	$-205.33M	$-90.96M	$-141.21M	$-56.95M	$-174.96M	$-90.64M	$-74.68M	$-60.57M	—	$-148.01M	$-131.97M	$-68.13M	—	$-118.61M	$-155.09M	$-104.95M	—	$-394.55M	$-485.68M	$-435.32M	—	—	—	$-207.54M	—	$-82.67M	$-62.94M	$-39.66M	—	$-43.65M	$-33.09M	$-44.00M	$-218.38M	$-36.27M	$-41.31M	$-36.75M	$-39.85M	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗
Revenue per Share (USD)	—	—	—	—	—	—	$0.00	$0.00	$0.00	—	$0.01	$2.15	$0.26	—	$0.03	$0.43	$0.34	—	$0.04	$0.19	$0.07	—	$0.09	$0.06	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.69	$-0.73	$-0.74	$-0.72	$-0.78	$-0.68	$-0.63	$-0.59	$-0.68	$-0.87	$-0.72	$1.34	$-0.80	$-0.75	$-0.84	$-0.48	$-0.53	$-0.62	$-0.69	$-0.50	$-0.58	$2.30	$-0.54	$-0.56	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.72	—	$-0.63	$-0.46	$-0.80	—	—	—	$-0.77	—	—	—	$-0.45	—	—	—	$-0.62	—	—	—	$-0.44	—	$-0.01	$-0.41	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$5.84	$6.49	$6.32	$7.05	$7.73	$8.53	$9.17	$9.69	$10.21	—	$8.10	$8.64	$7.07	—	$6.55	$7.18	$7.47	—	$8.30	$8.83	$9.12	—	$8.21	$4.75	$5.17	—	—	—	$5.42	—	$4.91	$5.25	$5.82	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$5.61	$6.49	$6.32	$7.05	$7.73	$8.53	$9.17	$9.69	$10.21	—	$8.10	$8.64	$7.07	—	$6.55	$7.18	$7.47	—	$8.30	$8.83	$9.12	—	$8.21	$4.75	$5.17	—	—	—	$5.42	—	$4.91	$5.25	$5.82	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	186.64M	—	172.42M	171.45M	171.22M	—	169.46M	168.83M	149.40M	—	137.64M	137.05M	136.52M	—	123.47M	123.01M	122.67M	—	121.74M	121.29M	120.88M	—	107.49M	105.72M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗
Working Capital (USD)	$912.60M	$802.31M	$792.45M	$843.65M	$786.76M	$762.23M	$781.75M	$853.85M	$890.99M	—	$1.07B	$1.15B	$934.08M	—	$777.86M	$766.44M	$647.20M	—	$1.00B	$1.29B	$1.38B	—	—	—	$557.15M	—	—	—	$456.29M	—	$351.79M	$346.41M	$360.25M	—	—	—	—	—	—
Total Equity (USD)	$926.10M	$1.01B	$926.20M	$1.03B	$1.12B	$1.23B	$1.32B	$1.39B	$1.46B	$1.03B	$1.12B	$1.19B	$966.71M	$1.04B	$811.30M	$884.45M	$917.93M	$962.29M	$1.01B	$1.07B	$1.11B	$1.15B	$882.55M	$502.17M	$545.31M	$394.89M	$438.20M	$475.17M	$516.65M	$546.85M	$461.18M	$490.27M	$539.03M	$465.80M	—	—	—	$-94.15M	$-15.63M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	$0.00	$0.00	$0.00	$0.00	$0.00	$1.27M	$294.12M	$35.14M	$10.28M	$3.56M	$52.48M	$42.14M	$12.51M	$5.29M	$22.94M	$7.92M	$316.81M	$9.39M	$5.85M	$3.60M	$4.67M	$13.60M	$4.20M	$4.21M	$125.62M	$1.20M	$1.65M	$641.00K	$0.00	$0.00	$0.00	—	—	—
Depreciation Expense (USD)	$2.85M	$2.87M	$2.95M	$3.04M	$2.33M	$1.85M	—	—	$2.16M	$2.18M	—	—	$10.05M	$4.09M	—	—	$2.08M	$2.09M	—	—	$2.11M	$2.12M	$2.16M	$2.15M	$2.11M	$2.06M	$1.89M	$1.64M	$2.40M	$2.38M	$2.33M	$1.85M	$854.00K	—	$778.00K	$766.00K	$731.00K	—	—
Net Income, GAAP (USD)	$-128.45M	$-128.55M	$-126.90M	$-124.12M	$-132.97M	$-114.75M	$-107.19M	$-99.03M	$-101.80M	$-119.47M	$-99.35M	$183.38M	$-109.78M	$-98.68M	$-103.30M	$-58.79M	$-65.22M	$-75.26M	$-84.59M	$-60.69M	$-70.04M	$244.88M	$-58.23M	$-58.76M	$-56.76M	$-54.02M	$-46.26M	$-58.34M	$-38.99M	$77.53M	$-35.37M	$-54.72M	$-23.68M	$-22.89M	$-21.84M	$-22.13M	$-21.32M	—	—
Operating Cash Flow (USD)	$-131.20M	$-98.54M	$-107.30M	$-75.30M	$-131.47M	$-83.72M	—	—	$-113.62M	$-98.66M	—	—	$-58.80M	$-72.66M	—	—	$-72.11M	$-65.49M	—	—	$-50.24M	$513.91M	$86.00K	$-43.36M	$-54.49M	$-47.64M	$-30.43M	$-43.17M	$-30.32M	$93.19M	—	—	—	$-18.34M	—	—	—	—	—

Denali Therapeutics Inc.

Analytical Summary

39-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare DNLI with peers